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Rabbits immunized with purin-6-oyl-protein conjugates form antibodies with 
purine  specificity.  These  antibodies  are  capable  of fixing complement  (C  t)  in 
the  presence  of  thermally  denatured  deoxyribonucleic  acid  (DNA).  This  re- 
action was found to be specifically inhibited by purines and purine derivatives 
(1).  Since the purines in DNA are linked to the deoxyribose-phosphate  "back- 
bone" at the 9-position, while the antipurinoyl antibody was elicited in response 
to  an antigen  in  which  the  purine  was  coupled  via the  6-position,  it  was not 
clear  whether  the  specific reaction  with  DNA  was characteristic  of the  total 
antipurinoyl  antibody in the  antisera,  or whether  this  reaction  was typical of 
a  relatively small proportion of the antibody.  This report shows that the reac- 
tions  of antipurinoyl  sera  with  DNA  and  with  purinoyl-protein  antigens  are 
similar in specificity.  In addition,  it  contains  a  demonstration  of the  reaction 
between antipurinoyl  sera and thermally denatured  DNA by the techniques of 
radioimmunoelectrophoresis  (2, 3) and passive cutaneous  anaphylaxis (4). 
Materials and Methods 
Proteins.--Bovine serum albumin (BSA), human serum albumin (HSA), and rabbit serum 
albumin  (RSA)  each  were  obtained  as  fraction V  from  Pentex,  Inc.,  Kankakee,  Illinois. 
Putin-6-oyl-BSA  (Pur-BSA)  and  purin-6-oyl-HSA  (Pur-HSA)  were  synthesized  by  the 
addition of 6-trichloromethylpurine  (5, 6) to BSA and HSA, respectively,  at pH 10.5. The 
details  of these syntheses  and  the  characterization  of the  conjugates  have been described 
previously (1); the Pur-BSA and Pur-HSA conjugates  contained,  respectively,  an estimated 
24 and 27 purinoyl residues  per molecule of serum albumin (1). 
Nucleic Ac/ds.--Pneumococcal  DNA was prepared by the method of Hotchkiss (7). Calf 
thymus DNA was obtained from Mann Research Labs, New York (Lot A 6379). T5 bacterio- 
phage DNA-C  14 (specific activity =  1.34/zc/mg), prepared from Escher/~/,/a coli grown in 
a  medium containing  radioactive  purines  and pyrimidines,  was generously  supplied  by Dr. 
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Aaron Bendich,  Sloan-Kettering Institute,  New York,  for use in  the radioimmunoelectro- 
phoresis experiments. 
Pneumococcal DNA, in concentrations of 1 to 10/zg/ml in isotonic NaC1 buffered at pH 
7.5 with veronal or tris, was denatured  by heating for 10 minutes in a  boiling water bath 
followed by immediate chilling.  The T5 DNA-C  14 was denatured at concentrations of 190 to 
200 #g/ml. The denaturation  of DNA used  in passive cutaneous  anaphylaxis  experiments 
is described separately under Immunochemical Procedures. 
Deoxyribonuclease Treatment.--Pneumococcal  DNA (15.8 ]zg/ml) was incubated for i  hour 
at 37°C with pancreatic DNAase  (Worthington  Biochemical Corp.,  Freehold, New Jersey; 
6.0 #g/ml) in an isotonic tris-buffered saline solution, pH 7.5, containing 5.2 X  10  -a ~  Mg  ++ 
and  7 X  10  -5~Ca ++ • 
Hapteus.--N-Purin-O-oyl-¢-aminocaproic  acid  and  hr-purin-6-oyl-f~-alanine  were  synthe- 
sized  by  the method  of Cohen,  Thorn,  and  Bendich  (6).  Purine-5-carboxylic acid  methyl 
ester  (5), N-purin-6-oyl-glycine (6), purine-6-carboxamide  (8),  and 9-methylpurine (9) were 
kindly supplied by Dr. Sasson  Cohen and Dr. Aaron Bendich. All other haptens used were 
commercial products  of standard  purity. 
Immunoehemical  l~rocedures.--Rabbits  were injected once weekly for  3  weeks into  the 
foot-pads (10) with Pur-BSA or Pur-HSA in complete Freund's adjuvant mixture. Beginning 
5 to 7 days after the last injection, the rabbits were bled three times by cardiac puncture and 
were finally exsanguinated 14 days after the last injection. All twenty-six animals immunized 
produced  antibodies which precipitated  with both  purinoyl-protein  conjugates. 
Globulin fractions were prepared by a modification (11) of the sodium sulfate precipitation 
method of Kekwiek (12). 
Antipurinoyl antibody was purified by the method  developed by  Mage,  et al.  (13) for 
obtaining antiglucosyl and antigalactosyl antibodies, as follows: Enough Pur-HSA was added 
to E2241 anti-Pur-BSA to precipitate all of the antibody  (60 ~g PUr-HSA nitrogen per ml 
antiserum). After washing,  the specific precipitate was dissolved by addition of excess purin- 
6-oyl-/~-alanine  (Pur-fl-Ala)  in 0.01  ~  phosphate  solution, pH 8.5.  The supernatant  of the 
resulting mixture was chromatographed on a  column (2 x 40 cm) of DEAE-sephadex A-25, 
previously equilibrated with 0.01 ~  phosphate buffer, pH 7.1. Pur-HSA and Pur-fl-Ala were 
retarded in their passage and the first peak of ultraviolet (280 m/z)-absorbing material which 
passed  through  the column consisted mainly of antibody.  This eluate was lyophilized, re- 
dissolved in a small volume of water, and chromatographed on a column (2 x 40 cm) of sepha- 
dex G-25  (medium) equilibrated with 0.01 ~  phosphate,  pH 7.2. The first peak of 280 re#- 
absorbing material was collected. This solution was dialyzed against running tap water for 
6  hours  and  was  then  lyophilized. Spectroscopic analysis indicated  that  the final product 
was free of hapten. It contained only "),-globulin detectable on immuneelectrophoretic analysis. 
This preparation of purified antipurinoyl antibody was 78 per cent precipitable upon the addi- 
tion of Pur-HSA at equivalence. 
Quantitative precipitin data were obtained using  the  Folin-Ciocalteu color  reaction  for 
analysis of specific precipitates  (14).  Hapten inhibition studies of precipitin reactions were 
carried  out in the equivalence zone. AU haptens  used in precipitin inhibition studies were 
dissolved in tris-buffered saline (0.02  u  tris in 0.85 per cent saline)  at pH 7.5. 
C r  fixation studies  were performed  using  the  quantitative  method  of  Wasserman  and 
Levine (15);  7.0 ml reaction volumes were employed. A veronal buffer  (16),  containing 0.1 
per cent BSA or RSA, was used in some early experiments. However, to avoid any possible 
artifacts that might have arisen from the presence of veronal, which is formally a hexahydro- 
pyrimidinetrione, a tris-HCl buffer was used in most of the experiments reported herein. The 
tris-HC1 buffer was made as follows:  2  liters of a  stock solution were prepared  containing 
81.6 gm NaC1,  12.1 gin tris [tris(hydroxymethyl)aminomethane;  Sigma Chemical Company, V.  P,  BUTLER~ JR.~ S.  W.  TANEN~AUM~ AND  $. M.  BEISER  21 
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St. Louis] and enough 2 N HCI (40 to 42 ml) to adjust the pH to 7.45-7.55. The stock solu- 
tion was diluted 1:5 and RSA was added to a  concentration of 0.1  per cent, Mg  ++ to 5  X 
10  -4 vl and Ca  ++ to 1.5 X  10  -4 M for C' fixation studies. DNA (prior to denaturation only) 
and haptens were dissolved in the buffer without the addition of RSA. 
Immunoelectrophoresis experiments  were  performed  on  microscope  slides  according  to 
the  method  of  Scheidegger  (17).  Duck  anti-rabbit serum  used  in  these  experiments was 
kindly supplied by Dr. Charles L. Christian, Columbia University, New York. 
In the radioimmunoelectrophoresis experiments, DNA-C 14 was added  together with the 
duck  antiserum to  the antiserum troughs.  After  72  hours,  the slides were  washed  several 
times, dried, and affixed  to strips of Kodak no-screen x-ray film for 5 to 14 days. The auto- 
radiograms were then developed and compared with the immunoelectrophoretic precipitates. 
Passive cutaneous anaphylaxis (PCA) was carried out as described by Ovary (4). Guinea 
pigs were injected intradermally with 0.1 ml aliquots of 1:100, 1:1000 and 1 : 10,000 dilutions 
of antipurinoyl serum.  Five hours later they were challenged by the intravenous injection 
of 0.5 ml of antigen solution mixed with 0.5 ml of 1 per cent Evans blue dye. Thirty minutes 
after this challenge, the reactions were read and recorded as  the diameter of visible intra- 
dermal extravasation of Evans blue dye.  An extravasation 5  mm or more in diameter was 
interpreted as a  positive reaction. Difficulties were encountered in the denaturation of DNA 
for this procedure because the concentrations required are greater than those at which optimal 
denaturation of DNA can be achieved. The calf thymus DNA was denatured at a concentra- 
tion of 2.5 mg/ml in 0.85 per cent saline and became gelatinous. Partial dispersion was achieved 
with a  syringe and it  was possible to  inject this material intravenously (in this instance, 
1.0 ml of the DNA preparation was injected with 0.5 ml dye). Pneumococcal DNA was de- 
natured at a  concentration of 2 mg/ml in aqueous solution and did not become gelatinous; 
after mixing with equal volumes of 1 per cent Evans blue dye (in 0.85 per cent saline), native 
and denatured pneumococcal DNA's were injected intravenously at  final concentrations of 
1 mg/ml. 
RESULTS 
Sera  E22-27,  E22-29,  E22-30,  E22-41  (anti-Pur-BSA)  and  E22-42  (anti- 
Pur-HSA)  were studied  extensively.  Quantitative  precipitin values  obtained 
upon addition of various antigens to sera E22-27 and E22-29 are presented in 
Fig.  1. In both instances,  relatively small amounts of antibody  were precipi- 
tated  by BSA  or HSA compared with the much larger precipitates  obtained 
with Pur-BSA  or Pur-HSA.  This has been noted with all antipurinoyl  sera 
studied to date. The small amount of antibody formed to the "backbone" pro- 
tein of the  antigens may be  due  to the  relatively large numbers of purinoyl 
residues in the conjugates. 
For further characterization of the specificity of these antisera, the ability of 
various haptens to inhibit the precipitin reactions between Pur-HSA and three 
anti-Pur-BSA globulin preparations was studied. In Figs. 2 a and 2 b the data 
are  recorded as  the per cent  inhibition,  by given amounts  of hapten,  of the 
precipitin reactions between Pur-HSA and the globulin fractions from antisera 
E22-27  (Fig. 2 a) and E22-30 (Fig. 2 b). In Table I are listed the quantities of 
each hapten required for 50 per cent inhibition of the precipitin reactions be- 
tween Pur-HSA  and globulins from antisera E22-27,  E22-29,  and E22-30.  It V.  P.  BUTLER~ JR.,  S.  W.  TANENBAUM~ AND S.  M.  BEISER  25 
can be seen from Figs. 2 a and 2 b and Table I  that the relative order of effec- 
tiveness of haptens as inhibitors of these precipitin reactions showed but minor 
variations  among  the  three  antisera  studied.  N-Purin-6-oyl-~-aminocaproic 
acid was the most effective of all the haptens studied. All compounds containing 
the purin-6-oyl structure were extremely effective inhibitors.  In general, most 
other purines and purine derivatives were moderately good inhibitors whereas 
pyrimidines were relatively poor inhibitors. Although it has been reported that 
TABLE I 
Quantity, in I~moles, of Various Haptens Required to Produce 50 Per Cent Inhibition* of 
the Precipitgn Reaction between Pur-HSA and Anti-Pur-BSA at Equivalence 
Hapten 
N-Purin-6-oyl-e-aminocaproic 
acid ......................... 
N-Purin- 6-oyl-glycine  ............ 
Purine-6-carboxamide ........... 
Hypoxanthine .................. 
6-Methylpurine ................. 
Adenine ....................... 
Deoxyadenosine ................ 
Uracil ......................... 
Adenosine ..................... 
9-Methylpurine ................. 
Thymine ....................... 
Cytosine ....................... 
e-Aminocaproic acid ............. 
E22-27 
/Jmoles 
0.01 
0.05 
0.13 
1.5 
3.6 
5.2 
12.0 
14.0 
>11.4 
>13.4 
>15.0 
>17.3 
>30.2 
Anti-Pur-BSA 
E22-29 
~moles 
0.005 
0.36 
0.4 
3.0 
>8.0  (30) 
>20.0  (29) 
>15.o  (3) 
(33)  >20.0  (27) 
(24) 
(21)  >20.0  (8) 
(21)  >20.0  (lO) 
(4)  >30.0  (0) 
E22~0 
0.01 
0.10 
0.25 
1.3 
6.0 
7.0 
9.8 
12.0 
>11.4  (32) 
>13.4  (7) 
>15.0  (17) 
>17.3  (12) 
>30.2  (0) 
* Instances where 50 per cent inhibition was not attained,  largest quantity of hapten used 
is listed, followed, in parentheses by per cent inhibition achieved by that amount of hapten. 
high concentrations  of e-aminocaproic acid are  capable  of inhibiting  antigen- 
antibody reactions  (18),  no such  effect was observed with  the  concentrations 
used in these experiments (Table I). 
Antipurinoyl sera are capable of fixing C' in the presence either of purinoyl- 
protein conjugates or of denatured pneumococcal DNA. These  C' fixation re- 
actions have been compared in the case of each of the five sera studied.  The 
ability of purinoyl-protein conjugates to fix C' by reacting with each of these 
sera is shown in Fig.  3.  The reactions  of each of four antipurinoyl sera in C' 
fixation with  native  and denatured  pneumococcal DNA are  shown in Fig.  4. 
In Table II are listed the highest dilutions of each antiserum which exhibited 
maximal C' fixation in the 75 to 90 per cent range upon the addition of purinoyl- 26  REACTIVITY  OF  AbTTIPU'REgOYL  SERUM  WITH  DNA 
protein conjugates or of denatured pneumococcal DNA.  In all instances the 
titers were lower with DNA than they were with purinoyl conjugates. 
It can be seen from the data presented in Fig. 4 that, as has been previously 
reported (1), the ability of native DNA  to fix C'  was  negligible, whereas a 
maximum C ~ fixation of about 80 per cent was observed when denatured DNA 
was added to comparable dilutions of each antiserum. At dilutions of 1:100, 
antisera E22-29 and E22-30 showed some reactivity with native DNA (Fig. 5). 
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Antigen was Pur-HSA except for E22-42, in which case Pur-BSA was used. 
This reactivity was, however, slight when compared with the almost complete 
fixation of C t observed with much smaller concentrations of denatured DNA, 
and may reflect the presence of traces of denatured DNA in the native prepara- 
tion used. The anticomplementary properties of all antipurinoyl sera at dilu- 
tions of 1: 75 and less prevented studies of this type with the other antisera. 
In other experiments, pneumococcal DNA was treated with DNAase prior 
to denaturation. In all instances studied, the reaction of the denatured DNA 
was abolished by such prior treatment with DNAase. 
The capacity of various haptens to inhibit the C' fixation reaction between 
DNA and antiserum E22-29 is depicted in Fig. 6. The quantity, in micromoles, 
of each hapten required for 50 per cent inhibition of this reaction is listed in V.  P.  BUTLER~ JR.,  S.  W.  TANENBAUM~ AND  S.  M.  BEISER  27 
I00 
z 
o 
I- 
x  80 
i- 
z 
w  60 
_1 
n 
40  o 
o 
i-- 
z 
,,,  2O 
L) 
a. 
0  0.2  0.4  0.6  0.8  1.0  1.2 
MICROGRAMS  PNEUMOCOCCAL  DNA 
FIo. 4. C ~  fixation reactions between native (dosed symbols) and denatured (open symbols) 
DNA and 1.00 ml of 
E22-27 (1:75 dilution),  •  [] 
E22-29 (1:350 dilution), •  A 
E22-30 (1:400 dilution), •  O 
E22-41 (1:80 dilution),  •  V 
TABLE II 
C  I Fixation Titcrs of Antipurinoyl Sera with Purinoyl-Protdns and 
with Denatured Pneumococcal DNA 
Antiserum 
E22-27 AntbPur-BSA. 
E22-29 Anti-Pur-BSA.. 
E22-30 Anti-Pur-BSA.. 
E22-41 Anti-Pur-BSA.. 
E22-42 Anti-Pur-HSA.. 
Antipurinoyl 
antibody 
concentration 
297 
199 
235 
183 
249 
Pur-HSA 
1:600 
1:600 
1:800 
1:740 
C' fixation  titem* 
Pur-BSA 
1:1200 
DNA 
1:75 
1:350 
1:400 
1:80 
1:80 
* Titers are recorded as highest dilutions capable of producing maximal C' fixation  in 
the 75 to 90 per cent range. 
Table HI; similar data for serum E22-30, previously reported (1), are also pro- 
vided for comparison. Comparable data for serum E22-27 could not be obtained 
with precision because of its marked anticomplementary properties. These data 
with  serum  E22-27  are  therefore,  best  considered  as  approximate  values 
(Table  HI).  Again,  as  with  the  corresponding  precipitation  reactions  with 28  REACTIVITY  OF  ANTIPURINOYL  SEREM  WITH  DNA 
Pur-HSA  (Table  I)  purinoyl-,-aminocaproic  acid  was  invariably  the  best 
hapten inhibitor of the C' fixation reactions with DNA (Table III). Although 
the relative quantities of other haptens required to inhibit the reaction with 
DNA varied from the quantities required to inhibit the reaction with Pur-HSA, 
the relative order of effectiveness of these haptens as inhibitors of the reaction 
with DNA  (Table III) paralleled their order of effectiveness as inhibitors of 
precipitation with Pur-HSA (Table I) rather closely. 
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Antipurin-6-oyl antibody was purified to demonstrate that the reactivity of 
antipurinoyl sera with DNA was an integral property of this antibody. The 
ability of the purified antibody preparation to fix C' in the presence of de- 
natured pneumococcal DNA is indicated in Table IV. 
The  reaction  of  antipurinoyl sera  with  DNA  was  demonstrated  by  yet 
another imrnunochemical method, namely that of radiolmmunoelectrophoresis 
(2, 3). By this technique, reactivity of denatured, C14-1abeled, 2"5 bacteriophage 
DNA with the ~,-globulin of antipurinoyl serum or with purified antipurinoyl 
antibody could be demonstrated (Fig. 7). In control experiments, the reaction 
of unheated preparations  of this labeled DNA  with the ~,-globulin  of anti- 
purinoyl sera was not observed. Denatured radioactive DNA was not bound 
by the ~/-globulin of sera obtained from normal animals or from animals immu- 
nized with other antigens. In several instances, both with control and with =,, 
(i 
w 
! 
I 
0 
0 
I  I  I  I 
0  0  0  0 
NOIIIBIHNI  IN'I:)  U3d 
0 
o~ 
q 
8 
m  ,'d 
d 
~8  ~a 
~  b 4 
8  ~g 
~  ,~.~ 
0o  -~i 
29 30  REACTIVITY  OF  ANTII:~U'RINOYL SERU'~  WITH  DNA 
TABLE  III 
Quantity, in grades, of Various Haptens Required to Produce 50 Per Cent Inhibition* of 
C' Fixation Reaction between Denatured Pneumococeal  DNA and 
Anti-Pur-BSA Serum 
Hapten 
N-Purin-6-oyl-e-aminocaproic 
acid .......................... 
N-Purin-6-oyl-glycine ............ 
Purine-6-carboxamide ............ 
Purine-6-carboxylic acid methyl 
ester ......................... 
Hypoxanthine ................... 
6-Methylpurine ................. 
Adenine ........................ 
Deoxyadenosine ................ 
Uracil ......................... 
Adenosine ...................... 
9-Methylpurine ................. 
Thymine ....................... 
Cytosine ....................... 
e-Aminocaproic acid ............. 
E22-27:~ 
pmoles 
<0.01  (85) 
<o.o14  (84) 
,~0.04 
Rabbit anti-Pur-BSA serum 
E22-29  E22-3O§ 
$traole$ 
<O.Ol  (lOO) 
<0.02  (89) 
O.Ol 
gmolts 
,--,0.03 
<0.22  (84) 
~3.0 
,'~1.5 
0.0004 
0.0009 
0.002 
0.01 
0.02 
<o.o4  (70) 
0.08 
O.lO 
5.2 
0.25 
0.84 
2.1 
0.60 
>3.4  (14) 
<0.06 
<0.11 
0.12 
0.30 
0.70 
>4.5 
0.70 
1.0 
1.5 
5.4 
(85) 
(75) 
(4O) 
* In instances where 50 per cent inhibition was not observed, largest or smallest quantity 
of hapten tested is listed, followed, in parentheses, by per cent inhibition observed with that 
amount of hapten. 
:~ Approximate values (See text for explanation). 
§ From reference 1. 
TABLE  IV 
Per Cent C' Fixation Observed on Addition of Denatured Pneumocoeeal  DNA to Purified 
Anti-purin-6-oyl Antibody from Rabbit E22-41 
Antibody N used 
#g 
1.5 
3.0 
Denatured pneumococcal  DNA added 
0.51/~g  1.02/~g 
per cent  per cent 
16  46 
85  93 
antipurinoyl  sera,  some  binding  of  radioactivity  was  associated  with  an  a2- 
globulin which was  not  further identified. 
The reaction of E22-41 anti-Pur-BSA  with Pur-HSA  and with pneumococcal 
or calf thymus  DNA  could further be demonstrated  by the passive cutaneous V.  P.  BUTLER~  JR. 7  S.  W.  TANENBAUM,  AND  S.  M.  BEISER  31 
anaphylaxis  (PCA)  method  (4).  The results are shown in Table V.  Significant 
reactivity  with  Pur-HSA was observed with  a  1 : 10,000  dilution of this  anti- 
serum following the intravenous injection of 0.5 mg Pur-HSA.  Reaction with 
both pneumococcal and calf thymus DNA's was noted with a  1 : 100 dilution of 
FIG.  7.  Radioimmunoelectrophoresis. After  electrophoresis of antiserum  E22-30 (a)  and 
purified antipurinoyl antibody (b) in agar, duck anti-rabbit  serum and denatured T5 bacterio- 
phage DNA-C 14 were added  to the center trough.  Immunoelectrophoretic  pattern is at ]eft 
and corresponding autoradiogram is at right. 
antiserum. It is of interest that native and denatured pneumococcal DNA's, in 
equal amounts (1.0 mg), elicited approximately equivalent PCA reactions with 
this antiserum. Whether this represents reaction of antibody with native DNA 
or merely reflects in vivo degradation of the injected native pneumococcal DNA 
preparation  is not clear at  this  time. 32  REACTIVITY OF  ANTIPURINOYL SERUM WITIt DNA 
TABLE V 
Passive  Cutaneous Anaphylaxis Experiments  with E22-41  AnIi-Pur-BSA * 
Antigen injected: 
E22-41 serum 
dilution: 
1:100 
1:1,000 
1:10,000 
Pur-HSA  __HSA 
15  25  18  0  0 
0  8  8 
Native 
pneumococcal 
DNA 
18  10  12  0  0 
0  0  0  0  0 
0  0  0  0  0 
Denatured 
pneumcoccal 
DNA 
15  Trace 
0  0 
0  0 
Denatured 
calf thymus 
DNA 
13  20  15 
0  0  0 
0  0  0 
* Results recorded as diameter (in millimeters) of area of extravasation of dye 30 minutes 
after intravenous injection  of antigen-dye mixture.  Each vertical column represents  sites of 
three intradermal injections  of dilutions  of E22-41 antiserum in  one  guinea  pig.  Animals 
injected  with  DNA appeared to react  somewhat  more slowly  than animals injected  with 
Pur-HSA. 
DISCUSSION 
Rabbits  immunized  with  purin-6-oyl-protein  conjugates  produce  purine- 
specific antibodies  (Figs.  1 to 3; Tables I, II); only relatively small quantities 
of antibody with  specificity for the protein  carrier  (BSA  or HSA)  are formed 
(Fig.  1).  The  hapten  inhibition  data  for  the  precipitin  reactions  between 
Pur-HSA and three antipurinoyl sera (Figs. 2 a and 2 b; Table I) clearly indicate 
that purin-6-oyl-~-aminocaproic acid  is the  most effective inhibitor  of this  re- 
action yet tested. This observation strongly supports the assumption (1), based 
on spectrophotometric data and the preferential reactivity of 6-trichloromethyl- 
purine with free amino groups at a mildly alkaline pH (1, 6), that the purin-6-oyl 
residues of the Pur-protein conjugates are linked by covalent peptide bonds via 
the free ~-amino groups of lysine. All compounds thus far studied which contain 
the purin-6-oyl structure are likewise potent inhibitors;  they are more effective 
inhibitors  than  the purines  themselves or other purine  derivatives,  which  also 
implies that the conjugated linkage possesses the purin-6-oyl structure.  As has 
been noted,  other purine  derivatives are moderately effective inhibitors  of this 
reaction and pyrimidines possess a  slight inhibitory capacity. This latter prop- 
erty is not unexpected,  in view of the fact that the basic purine structure  con- 
tains the pyrimidine ring. 
It has  been  demonstrated  that  antipurinoyl  sera  fix  C'  in  the  presence  of 
thermally  denatured  pneumococcal  DNA  (Figs.  4,  5; Table II) and  that  this 
reaction of DNA with antipurinoyl  sera can be abolished by prior treatment of 
the  DNA  with  DNAase.  Serum  E22-30  has  previously been  shown  (1)  to fix 
C' with other thermally  denatured  bacterial  DNA's as well as with unheated, 
single-stranded  (19)  DNA from bacteriophage ~bX 174. 
The reaction of antipurinoyl  sera with denatured  DNA is best explained (1) V.  P.  BUTLER,  JR.,  S.  W.  TANENBAU~,  AND  S.  M.  BEISER  33 
in terms of current concepts of DNA structure (20), in which it is postulated 
that  thermal  denaturation  cleaves  weak  hydrogen  bonds  between  apposed 
purine and pyrimidine bases of the double helix, thereby separating the strands 
and rendering  the purine bases of the DNA more accessible for reaction with 
antipurinoyl antibody. Such preferential reactivity with thermally denatured, 
single-stranded  DNA was first noted by Levine and  coworkers with  rabbit 
antibodies to T-even bacteriophage DNA (21). In this instance the antibodies 
were shown to have specificity for an unusual glucosylated pyrimidine base, 
5-hydroxymethylcytosine  (22).  A  similar  preferential  reaction  with  single- 
stranded DNA has been described for the sera of many human patients with 
systemic lupus erythematosus  (23,  24).  Pyrimidine-specific  rabbit  antibodies 
which cross-react with DNA similarly exhibit greater reactivity with denatured 
DNA  (25),  although  some  reaction  with  native  DNA  is  found.  Recently, 
Timakov et al. (26) and Christian el a/. (27) have detected, in the sera of rabbits 
hyperimmunized with bacteria, antibodies which react better with denatured 
DNA than with native DNA. 
That the DNA-reactive antibody in the current study is purine-specific  can 
be  inferred  from  two observations,--first,  the pattern  of hapten  inhibition 
(Table III; Fig. 6), and second, the ability of purified antipurin-6-oyl antibody 
to react with denatured DNA, as demonstrated by C' fixation (Table IV) and 
radioimmunoelectrophoresis  (Fig.  7).  Prior  to  this  work it  was not  certain 
whether the antibody in antipurinoyl sera which reacts with DNA is repre- 
sentative of the total antipurin-6-oyl antibody or whether it represents a small 
fraction of the antibody with different specificity.  The hapten inhibition data 
(Table HI; Fig. 6) indicate that purin-6-oyl amino acids are the best inhibitors 
of the C p fixation  reaction between these sera and DNA, and that  the relative 
order of effectiveness of all haptens in this C r fixation" reaction closely parallels 
their relative order as inhibitors of the precipitin reaction between antipurinoyl 
sera and  Pur-HSA  (Table  I).  This  observation indicates  that  the  antibody 
which reacts with DNA is indeed representative of the total antipurin-6-oyl 
antibody in these sera. Of particular interest is the finding that 6-methylpurine 
is a  better inhibitor  than is 9-methylpurine of the reaction of antibody with 
DNA as well as of its reaction with PUr-HSA despite the fact that, as previously 
mentioned, purines in DNA are linked to deoxyribose at the 9-position.  The 
relative effectiveness  of these haptens  thus depends on the specificity of the 
antibody, and not on the structure of the particular cross-reacting antigen used 
to measure the effect. 
The titers of antipurinoyl sera were lower with DNA than they were with 
purinoyl-protein conjugates, both in C' fixation (Table II) and PCA (Table V) 
experiments. This was expected since the reactions with DNA are cross-reac- 
tions.  It should be noted that the ratio of the titers (with DNA and with the 
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amount of antibody involved in the reaction with DNA may actually be greater 
than that indicated by this ratio; for example, Osler and Heidelberger (28) have 
shown that about five times as much antibody may be required to fix a given 
amount of C  p when it reacts with a  cross-reacting antigen than is required to 
fix the  same  amount of  C' when the  antibody reacts  with  the  homologous 
antigen. 
It was found in the current study that 200 to 500 m~g precipitating anti- 
purinoyl N  were required to obtain maximal C  p fixation of 75 to 90 per cent 
with purinoyl-protein conjugates (cf. Table II). This finding is in accord with 
the observations of Reichlin, Wilson, and Levine (29),  who found that 70 to 
700 m#g antibody N are required to produce comparable C' fixation with rabbit 
antisera, the differences being related to the immunization schedule and the 
antigen being injected. In the cases of certain antisera, 20 to 40 m#g antibody 
N  have been sufficient to produce this degree of C' fixation (15),  but in these 
instances the antisera were obtained from hyperimmune animals (30).  Similar 
variations in the C'-fixing ability of rabbit anti-BSA have been correlated by 
Wallace, Osler,  and Mayer (31) with differences in immunization schedules. 
A well delineated zone of antigen excess was noted in all C' fixation reactions 
between purinoyl-protein conjugates and  antipurinoyl sera  (Fig.  3).  In  the 
curves depicting the C' fixation reactions between these antisera and denatured 
pneumococcal DNA (Figs. 4 and 5), however, no zone of antigen excess is seen. 
Whether a decrease in the percentage of C ~  fixation would be observed if larger 
quantities of DNA  were used cannot be  stated because  quantities of DNA 
greater than 2/zg exhibit significant anticomplementary activity in the C  ~  fixa- 
tion system used. Stollar and Levine (32)  have encountered a  few sera from 
patients with systemic lupus erythematosus which react maximally with rela- 
tively large amounts of denatured I)NA (1  ~g rather than 0.02 #g, which is 
optimal for most DNA-reactive lupus sera) and in which no zone of antigen 
excess can be demonstrated. These authors noted the similarity of the C t fixa- 
tion curves of these lupus sera with those of antipurinoyl sera and suggested 
that the requirement for a  relatively large amount of DNA may reflect the 
specificity of antibody for a relatively small repeating determinant unit, such 
as a  single base or a nucleotide (32). 
Using  the  technique of radioimmunoelectrophoresis, C14-1abeled denatured 
DNA was shown to bind to the "},-globulin of antipurinoyl sera and to purified 
antipurinoyl antibody. Since  the duck serum added with the  C14-DNA may 
have contained deoxyribonucleases, such as are present normally in the sera of 
many species  (33, 34),  the bound radioactivity could have represented either 
intact DNA or subunits derived from it. Sufficient radioactive DNA of satis- 
factory purity and specific activity was not available for further study of this 
question.  An  incidental finding in  the  course  of  these  experiments was  the V.  P.  BUTLER,  JR.,  S.  W.  TANENBAUM,  AND  S.  M.  BEISER  3~ 
binding of radioactivity to the a~-globulins of both normal and immlme sera. 
The role, if any, of these proteins in the transport and metabolism of deoxy- 
ribonucleic acid or its subunits remains to be investigated. 
The reactivity of antipurinoyl sera with DNA was further demonstrated by 
the PCA method (Table V). Native and denatured pneumococcal DNA's in 
equal  concentrations  elicited  approximately  equivalent  PCA  reactions.  The 
basis for the difference  in reactivity with native DNA by PCA as compared 
with that  observed in C' fixation and radioimmunoelectrophoresis is not ap- 
parent.  It is possible,  however, that  different classes  of antibodies are being 
detected by different methods. In this regard, the recent finding  (35) that dif- 
ferent classes of precipitating antibodies appear to be responsible in guinea pigs 
for C' fixation and PCA, respectively, may be particularly relevant. 
Recently it has been shown that  antipurinoyl sera,  as well as some other 
antipurine  and antipyrimidine  sera,  precipitate with certain denatured DNA 
preparations  (36).  Neither  precipitation  nor  C'  fixation  between RNA and 
antipurinoyl sera has been detected, but RNA, thermally denatured in the pres- 
ence of formaldehyde, can inhibit precipitation between the antipurinoyl sera 
and calf thymus DNA, also thermally denatured in the presence of formalde- 
hyde (37).  Some reactivity of antipurinoyl sera with RNA preparations was 
also  detected by PCA  and  radiolmmunoelectrophoresis.  In  these  instances, 
however, contamination of the RNA with DNA has not yet been excluded as a 
possible basis for the reaction. 
The reaction of antipurinoyl sera with DNA in v/tro has prompted a study 
of the effect of antipurinoyl sera in biological systems. It has been demonstrated 
that  antipurinoyl  antibody  inhibits  the  DNA-dependent  transformation  of 
pneumococci  from  streptomycin  sensitivity  to  streptomycin  resistance  (1). 
Antipurinoyl sera have also been demonstrated to exert drastic alterations on 
the development of fertilized sea-urchin eggs (38). The effect of these antisera 
on other biological  systems is under investigation. 
SUMMARY 
The  specificity of the  reaction  of antipurin-6-oyl  sera with  thermally  de- 
natured DNA has been studied by means of hapten inhibition techniques. The 
relative order of effectiveness of various haptens as irrhibitors of the complement 
fixation reaction between DNA and  antipurin-6-oyl  serum was found to be 
comparable to their relative order of effectiveness as inhibitors of the precipitin 
reaction  between purin-6-oyl-protein  conjugates  and  antipurin-6-oyl  serum. 
Antipurin-6-oyl antibody has been purified and has been shown to be capable 
of reacting with thermally denatured DNA. It is concluded that the reactivity 
of these  purine-specific  antisera  with  DNA  is  a  property of antibody with 
specificity for the purin-6-oyl moiety. 36  REACTIVITY  OF  ANTIPURINOYL SERUM  WITH  DNA 
In  addition,  the  reaction  between  antipurinoyl  sera  and  DNA  has  been 
demonstrated by  the  techniques  of radioimmunoelectrophoresis and  passive 
cutaneous anaphylaxis. 
We are indebted to Professor  Pierre Grabar who suggested the radioimmunoelectrophoresis 
experiments, to Dr. Zoltan Ovary who collaborated  with us in the PCA experiments, and to 
Dr. Aaron Bendich for many helpful discussions during the course of this study. We also 
wish to acknowledge the skillful technical assistance of Miss Genevieve  Winiarski and Mr. 
Burton Rosenberg. 
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